Sirpa A Tavakoli, Maria S Arguisola. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » AdultAnticonvulsants/adverse effectsAnticonvulsants/therapeutic useAntidepressive Agents, Second-Generation/adverse effectsAntidepressive Agents, Second-Generation/therapeutic useAntipsychotic Agents/adverse effectsAntipsychotic Agents/therapeutic useBenzodiazepinesBipolar Disorder/drug therapyCyclohexanols/adverse effectsCyclohexanols/therapeutic useDiabetes Mellitus/chemically inducedDiabetes Mellitus/diagnosisDiabetes Mellitus, Type 1/chemically inducedDiabetes Mellitus, Type 1/diagnosisDiabetic Ketoacidosis/chemically inducedDiabetic Ketoacidosis/diagnosisDrug InteractionsDrug Therapy, CombinationHumansMaleObesityOlanzapinePirenzepine/adverse effectsPirenzepine/analogs & derivativesPirenzepine/therapeutic useRisk FactorsValproic Acid/adverse effectsValproic Acid/therapeutic useVenlafaxine Hydrochloride
Substances: See more » AnticonvulsantsAntidepressive Agents, Second-GenerationAntipsychotic AgentsCyclohexanolsBenzodiazepinesPirenzepineValproic AcidVenlafaxine HydrochlorideOlanzapine
Year: 2003 PMID: 12940340 DOI: 10.1097/01.SMJ.0000078649.46905.B5
Source DB: PubMed Journal: South Med J ISSN: 0038-4348 Impact factor: 0.954